Cellular heterogeneity in hypertrophic burn scars in response to carbon dioxide laser therapy
Open Access
- 10 April 2026
- journal article
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Abstract
Ablative fractional carbon dioxide (AFCO2) laser therapy is used for treating pathological scarring. However, mechanisms underlying reduction in hypertrophic scarring are poorly understood. We investigated cellular mechanisms of AFCO2 laser therapy by performing single-cell RNA sequencing (scRNA-seq) on skin biopsies from burn survivors with hypertrophic scars before and after three sessions of AFCO2 therapy. Scar reduction was assessed subjectively and objectively. Those with a good response (GR) to laser therapy have scars less than 6 years from injury, whereas poor responders (PR) have scars over 6 years since injury. ScRNA-seq analysis of skin biopsies reveals that genes enriched in GR are associated with extracellular matrix and structure organisation (COL14A1, POSTN, SPARC); whereas genes enriched in PR are related to enhanced immune inflammatory responses (CXCL14, JUN, TNC). Notably, expression of the pro-fibrotic gene Engrailed-1 (EN1) remains elevated in PR scars compared to GR. The ECM-regulatory gene TIMP-1 (Tissue Inhibitor of Metalloproteinases 1) is also significantly upregulated in PR scars following treatment relative to GR scars, although at the protein level TIMP1 levels decrease in PR but increase in GR after therapy. The regenerative-associated gene, TRPS1 (Transcriptional Repressor GATA Binding 1) expression demonstrates opposing regulation post treatment, with upregulation observed in GR scars but downregulation in PR scars, underscoring distinct transcriptional trajectories associated with differential therapeutic outcomes. Finally, distinct intercellular communication networks and differentiation trajectories are observed after AFCO2, with regenerative mesenchymal fibroblasts predominating in GR but inflammatory fibroblasts associated with PR. We conclude AFCO2 laser therapy is more effective if done early after injury and distinct fibroblast recruitment is associated with a good response, specifically regenerative fibroblasts.Keywords
All Related Versions
Funding Information
- Scar Free Foundation
This publication has 69 references indexed in Scilit:
- Carbon dioxide laser treatment of burn-related scarring: Results of the ELIPSE (Early Laser Intervention Promotes Scar Evolution) prospective randomized controlled trialJournal of Plastic, Reconstructive & Aesthetic Surgery, 2023
- Minimally Invasive Technologies for Treatment of HTS and Keloids: Low-Dose 5-Fluorouracil2020
- Hypertrophic Scar Improvement by Early Intervention With Ablative Fractional Carbon Dioxide Laser TreatmentLasers in Surgery and Medicine, 2020
- Burns objective scar scale (BOSS): Validation of an objective measurement devices based burn scar scale panelBurns, 2020
- Randomized, Controlled Early Intervention of Dynamic Mode Fractional Ablative CO2 Laser on Acute Burn Injuries for Prevention of Pathological ScarringLasers in Surgery and Medicine, 2019
- Differential collagen–glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: Potential therapeutic targets for hypertrophic scarBiomaterials, 2011
- Skin responses to fractional photothermolysisLasers in Surgery and Medicine, 2006
- Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal InjuryLasers in Surgery and Medicine, 2004
- Skin elasticity meter or subjective evaluation in scars: a reliability assessmentBurns, 2004
- The Argon Laser for Cutaneous LesionsJAMA, 1982